From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma.

Molecular biology studies of uveal melanoma have resulted in the development of novel immunotherapy approaches including tebentafusp—a T cell–redirecting bispecific fusion protein. More biomarkers are currently being studied. As a result, combined immunotherapy is being developed as well as immunoth...

Descripción completa

Detalles Bibliográficos

Publicado en:	Current Oncology Vol. 31; no. 2; pp. 778 - 801
Autores principales:	Synoradzki, Kamil J., Paduszyńska, Natalia, Solnik, Malgorzata, Toro, Mario Damiano, Bilmin, Krzysztof, Bylina, Elżbieta, Rutkowski, Piotr, Yousef, Yacoub A., Bucolo, Claudio, Zweifel, Sandrine Anne, Reibaldi, Michele, Fiedorowicz, Michal, Czarnecka, Anna M.
Formato:	Journal Article
Publicado:	MDPI Feb2024
Acceso en línea:	Ver este registro en EBSCOhost